lactic acid has been researched along with salmeterol xinafoate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cayton, RM; Freeman, S; O'Hickey, SP; Robertson, W; Simkins, J | 1 |
Hantson, P; Manara, A; Thys, F; Vanpee, D | 1 |
Xu, J; Zhang, H | 1 |
1 trial(s) available for lactic acid and salmeterol xinafoate
Article | Year |
---|---|
Does single dose salmeterol affect exercise capacity in asthmatic men?
Topics: Adult; Albuterol; Asthma; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Exercise Test; Exercise Tolerance; Forced Expiratory Volume; Heart Rate; Humans; Lactates; Lactic Acid; Male; Physical Endurance; Potassium; Salmeterol Xinafoate | 1994 |
2 other study(ies) available for lactic acid and salmeterol xinafoate
Article | Year |
---|---|
Lactic acidosis following intentional overdose by inhalation of salmeterol and fluticasone.
Topics: Acidosis, Lactic; Administration, Inhalation; Adolescent; Adrenergic beta-2 Receptor Agonists; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Drug Administration Schedule; Drug Overdose; Drug Therapy, Combination; Female; Fluid Therapy; Fluticasone; Humans; Intention; Lactic Acid; Potassium; Salmeterol Xinafoate | 2012 |
Enhanced oral bioavailability of salmeterol by loaded PLGA microspheres: preparation, in vitro, and in vivo evaluation.
Topics: Administration, Intravenous; Administration, Oral; Adrenergic beta-Agonists; Animals; Biological Availability; Chemistry, Pharmaceutical; Emulsions; Excipients; Lactic Acid; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Salmeterol Xinafoate; Solubility | 2016 |